Follow The Filings

JUNS Jupiter Neurosciences

Jupiter Neurosciences earnings company data as of 4:47 AM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by JUNS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JUNS insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 5.03,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 3.01,8.01,9.01
8-K 1.01,5.02,8.01,9.01
8-K 8.01,9.01
424B5
8-K 1.01,3.02,8.01,9.01
10-Q
8-K 3.03,5.03,8.01,9.01
424B3
8-K 3.02,8.01,9.01
8-K 5.07,8.01,9.01
424B3
8-K 1.01,3.02,9.01
424B3
8-K 5.02,9.01
424B3
S-1
DEF 14A
8-K 5.02,9.01
424B3
8-K 5.02,9.01
424B3

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.